You are here:

ziconotide 100 micrograms/ml solution for infusion (Prialt)

Advice

Following a full submission

ziconotide (Prialt®) is not recommended for use within NHS Scotland for the treatment of severe, chronic pain in patients who require intrathecal analgesia. Ziconotide, compared to placebo, improved pain scores in patients with chronic severe intractable pain despite treatment with systemic and/or intrathecal analgesia.

However, the manufacturer did not present a sufficiently robust economic analysis to gain acceptance by SMC.

Drug Details

Drug Name: ziconotide 100 micrograms/ml solution for infusion (Prialt)
SMC Drug ID: 405/07
Manufacturer: Eisai Ltd
Indication: for the treatment of severe, chronic pain in patients who require intrathecal analgesia
BNF Category:
Sub Category: 4.7 Analgesics
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 8 October 2007

Back